However, our observation as frequent deregulation in the PDK-1/AKT/mTOR/p70S6K signalling pathway and its prognostic role in breast cancers implicated the notion of using inhibitors to impair this pathway and to provide additional strategy to treat breast cancer. The gene discussed is RPS6KB1; the disease is breast carcinoma.